Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO17059-T3

Drug Field of development:

Alzheimer’s disease Therapy Area:

Method Type of patent:

Pyk2-based gene therapy gene therapy attenuates cognitive deficits

In the present invention it is shown that the inactivation of the Pyk2 gene does not alter hippocampal development but prevents hippocampal-dependent […]

BIO17059-T1

Drug Field of development:

Huntington's Disease Therapy Area:

Method Type of patent:

Pyk2-based gene therapy attenuates cognitive deficits associated to

In the present invention it is shows that the inactivation of the Pyk2 gene does not alter hippocampal development but prevents hippocampal-dependent […]

BIO18215-T1

Drug Field of development:

Thalassemia Therapy Area:

Product Type of patent:

Methods for increasing fetal hemoglobin content in eukaryotic cells

The clinical severity of β-hemoglobinopathies is alleviated by the co-inheritance of genetic mutations causing a sustained fetal γ-globin chain […]

BIO17148-T1

Drug Field of development:

Genetic Disorders Therapy Area:

Product Type of patent:

Allele-specific silencing therapy for dynamin 2-related diseases

The invention relates to an allele specific siRNA able to silence the expression of only one allele of a heterozygous DNM2 gene, for treating diseases […]

BIO15066-T1

Drug Field of development:

Hepatitis c Therapy Area:

Product Type of patent:

Ex-vivo active immunotherapy against infectious diseases and tumoral

The present invention concerns lentiviral vectors enabling the expression of membrane-anchored and secreted antibodies by B cells. This invention […]

BIO15039-T1

Drug Field of development:

Others Therapy Area:

Product Type of patent:

Improved vector for driving the targeted integration of a transgene

The present invention relates to polypeptide for engineering integrase chimeric proteins and their use in gene therapy. A key challenge for gene […]

BIO15161-T1

Drug Field of development:

Alzheimer’s disease Therapy Area:

Method Type of patent:

Soluble appsα-based gene therapy in alzheimer’s disease

The present invention relates to a method of treating Alzheimer’s disease by administration to the subject of a therapeutically effective amount of […]

147

56

310

46

Our Technology Offers

Pyk2-based gene therapy gene therapy attenuates cognitive deficits

Pyk2-based gene therapy attenuates cognitive deficits associated to

Methods for increasing fetal hemoglobin content in eukaryotic cells

Allele-specific silencing therapy for dynamin 2-related diseases

Ex-vivo active immunotherapy against infectious diseases and tumoral

Improved vector for driving the targeted integration of a transgene

Soluble appsα-based gene therapy in alzheimer’s disease

You might also be interested in

Vdac1 inhibition for the treatment of peripheral

Pyk2-based gene therapy gene therapy attenuates

Pyk2-based gene therapy attenuates cognitive

Methods and composition to identify and treat

Compounds targeting hsp110 protein for cancer

Selective pharmacological inhibition of epac1 for

Nanoparticles for treating or preventing a

Methods and pharmaceutical compositions for the

Use of mast cell stabilizer for the treatment of

Methods and compositions for modulating

Correction of beta-thalassemia phenotype by

Use of inhibitors of phosphatase activity of

Contact

Inserm Transfert